Intravitreal Injection
11
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
18%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates
Endophthalmitis After Intravitreal Injection of Antiangiogenic Agents or Corticosteroids, a Cohort Study of the French Population of Patients Who Received Injections Over 9 Years
Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery
Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
Long Term Safety of Cooling Anesthesia for Intravitreal Injection
Pain Control and Subconjunctival Hemorrhage Size After Intravitreal Injection
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Cooling Anesthesia for Intravitreal Injection
Comfort Comparison of Intravitreal Injection Eyelid Retraction Techniques